Successful introduction of the Seegene STARlet-AIOS fully automated system with the AllplexTM STI Essential Assay, AllplexTM Genital Ulcer Assay and the AllplexTM HPV28 Genotyping Assay - Interview with the Dr. Risch AIOS-Team about the successful introduction of the Seegene STARlet-AIOS fully automated system with the AllplexTM STI Essential Assay, AllplexTM Genital Ulcer Assay and the AllplexTM HPV28 Genotyping Assay
Succesful implementation of Quantum Blue­® Adalimumab and Anti-Adalimumab - Learn how Dr. Bernard Royer from the Clinical Pharmacology and Toxicology Service at the Centre Hospitalier Universitaire de Besançon, France, significantly improved turnaround time and streamlined testing processes by adopting the BÜHLMANN therapeutic drug monitoring assays.
Successful introduction of the fully automated Seegene STARlet-AIOS system with the AllplexTM STI Essential Assay and the AllplexTM GI-EB Screening Assay - Interview with Christophe Zehnder about the successful introduction of the fully automated Seegene STARlet-AIOS system with the AllplexTM STI Essential Assay and the AllplexTM GI-EB Screening Assay

Assises Nationales des MICI 2024

Date: 26 January 2024
Location: Beffroi de Montrouge, France

17e Assises Nationales des MICI

MEDLAB Middle East 2024

Date: 5 – 8 February 2024
Location: Dubai, U.A.E.

MEDLAB Middle East 2024. Visit our booth #Z3.D33.

ECCO 2024

Date: 21 – 24 February 2024
Location: Stockholm, Sweden

Inflammatory Bowel Diseases – 18th Congress of ECCO. Visit our booth #A26.

AAAAI 2024

Date: 23 – 26 February 2024
Location: Washington, DC, USA

Annual Meeting of the American Academy of Allergy, Asthma & Immunology